Versavo 100 mg Injection
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Versavo 100 mg Injection

Versavo 100 mg Injection

Versavo 100 mg Injection contains bevacizumab 100 mg, a targeted anticancer medicine used for several advanced and metastatic cancers. It is administered as an intravenous infusion by a qualified healthcare professional. Bevacizumab blocks VEGF-A, helping reduce the formation of new blood vessels that support tumor growth.

BUY NOW

Category

Versavo 100 mg Injection is used in treatment regimens for colorectal, non-small-cell lung, kidney, ovarian, cervical and other cancers depending on the clinical indication. Bevacizumab is a monoclonal antibody that binds to VEGF and inhibits tumor angiogenesis. It may be given with chemotherapy or other anticancer medicines according to the prescribed treatment protocol. The dosage and treatment schedule are determined by the treating oncologist based on the patient’s condition and response to treatment.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Dosage Form Concentrate for Solution for Infusion
Route Intravenous Infusion
Pack Size 1 Vial of 4 mL
Manufacturer/Marketer Dr. Reddy’s Laboratories Ltd.

Product Also Known As

Versavo 100 mg Injection, Versavo 100 Injection, Versavo Bevacizumab Injection, Bevacizumab 100 mg Injection, Bevacizumab Cancer Injection, Bevacizumab Anti-VEGF Injection